Care este prețul pentru Celyad Oncology S.A. (CYAD)

Prețul pentru Celyad Oncology S.A. (CYAD) este $0.343985

Care este capitalizarea de piață pentru Celyad Oncology S.A. (CYAD)

Capitalizarea de piață pentru Celyad Oncology S.A. (CYAD) este $15.40M

Celyad Oncology S.A. (CYAD) Preț și Capitalizare de Piață

Celyad Oncology S.A. is a clinical-stage biopharmaceutical firm dedicated to pioneering and advancing chimeric antigen receptor T (CAR-T) cell therapies specifically for oncology. Its most advanced therapeutic programs include several candidates undergoing clinical trials. CYAD-101 is an allogeneic CAR-T treatment currently in a Phase 1b study targeting metastatic colorectal cancer. Another allogeneic candidate, CYAD-211, utilizes short hairpin RNA (shRNA) technology and is being evaluated in a Phase 1 trial for patients with relapsed or refractory multiple myeloma. Furthermore, CYAD-02, an autologous CAR-T therapy, is progressing through a Phase 1 study to address relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes. In its preclinical pipeline, the company is developing CYAD-203. This is a non-gene-edited allogeneic CAR-T candidate designed to co-express interleukin-18 (IL-18) cytokine with natural killer group 2D ligands (NKG2D), intended for the treatment of various solid tumors. Celyad Oncology holds a licensing agreement with Novartis International AG, granting rights to U.S. patents concerning allogeneic CAR-T cells. Additionally, it has established research and development collaborations and licensing agreements with Horizon Discovery Group plc, leveraging their shRNA technology to create an alternative non-gene-edited allogeneic platform. Established in 2004, the company was initially known as Celyad SA before rebranding to Celyad Oncology SA in June 2020. Its headquarters are situated in Mont-Saint-Guibert, Belgium.

Prețul pentru CYAD	Activul B	Capitalizarea de piață a B	Rezultate
$118,933 $15.40M	NVDA	$5.324T	+34,575,028.85%
$101,905 $15.40M	AAPL	$4.561T	+29,624,676.11%
$92,558.35 $15.40M	GOOG	$4.143T	+26,907,570.31%
$79,836.22 $15.40M	MSFT	$3.574T	+23,209,114.21%
$62,771.11 $15.40M	AMZN	$2.810T	+18,248,112.58%

Prețul pentru CYAD

Activul B

Capitalizarea de piață a B

Rezultate

$118,933 $15.40M